Ascentage Pharma (AAPG) said late Tuesday that it closed its initial public offering of almost 7.33 million American depositary shares at $17.25 per ADS, raising about $126.4 million in gross proceeds.
Each ADS represents four ordinary shares of Ascentage Pharma.
The company granted underwriters a 30-day option to purchase up to almost 1.1 million additional ADSs.
The ADSs began trading on the Nasdaq Global Market on Jan. 24.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.